2023 Head & Neck Cancer Conference Guide Book
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The RACE to overcome the crisis in<br />
<strong>Head</strong> and <strong>Neck</strong> cancers<br />
Oracle <strong>Cancer</strong> Trust<br />
Since Oracle was founded, we have funded over<br />
£8million of research projects. Our research<br />
focus is to provide support and funding for<br />
projects that result in better understanding,<br />
data and improved patient outcomes for those<br />
affected by <strong>Head</strong> and <strong>Neck</strong> cancers.<br />
<strong>Head</strong> and <strong>Neck</strong> cancers are the 4th most<br />
common cancer in men in the UK and the 7th<br />
overall. Around 12,400 people are diagnosed with<br />
a <strong>Head</strong> and <strong>Neck</strong> cancer each year with growing<br />
levels of late-stage diagnoses, low public<br />
awareness and poor rates of mortality.<br />
Patients are often left with debilitating<br />
appearance, speech, eating, swallowing and/or<br />
respiratory problems as well as psychological<br />
effects of loss of function and change in body<br />
image.<br />
Oracle <strong>Cancer</strong> Trust is the UK’s leading <strong>Head</strong> and<br />
<strong>Neck</strong> <strong>Cancer</strong> charity. Our mission is to improve<br />
<strong>Head</strong><br />
and <strong>Neck</strong> <strong>Cancer</strong> patient quality of life<br />
and outcomes in the UK.<br />
Our charity’s purpose and activities are all<br />
aimed at improving quality of life<br />
outcomes for <strong>Head</strong> and <strong>Neck</strong> cancer<br />
patients. To this end, Oracle <strong>Cancer</strong> Trust<br />
supports and runs 4 types of projects:<br />
Research projects: Oracle <strong>Cancer</strong> Trust<br />
supports research projects that<br />
demonstrate potential to deliver and<br />
drive greater understanding about <strong>Head</strong><br />
and <strong>Neck</strong> cancers, how best to treat<br />
them and where the greatest unmet<br />
needs are. This includes 1) lab-based<br />
medical research projects, 2) data<br />
gathering and analysis of disease and<br />
patient trends, and 3) qualitative and<br />
behavioural research projects.<br />
Awareness campaigns: Oracle <strong>Cancer</strong><br />
Trust drives, delivers and supports<br />
awareness campaigns focused on <strong>Head</strong><br />
and <strong>Neck</strong> cancers<br />
Collaboration programmes: Oracle<br />
<strong>Cancer</strong> Trust promotes and supports<br />
collaboration and creates key<br />
opportunities for knowledge sharing and<br />
agreeing best practice within <strong>Head</strong> and<br />
<strong>Neck</strong> cancers<br />
Experience of patients: Oracle <strong>Cancer</strong><br />
Trust will support, promote and<br />
encourage more focus and<br />
understanding on the patient experience<br />
within <strong>Head</strong> and <strong>Neck</strong> cancers.<br />
Oracle jointly funded a new study that suggests<br />
robotic surgery has high cure rates for some<br />
<strong>Head</strong> and <strong>Neck</strong> cancer patients. Published in<br />
the Journal of the National <strong>Cancer</strong> Institute,<br />
results from the RECUT study reveal that,<br />
following transoral robotic surgery (TORS), the<br />
two-year overall survival rate for recurrent head<br />
and neck cancer patients whose recurrence has<br />
been detected at an early stage is nearly three<br />
quarters (72%). This improves on other<br />
treatments currently available to this patient<br />
group, which often includes further<br />
radiotherapy or open surgery, in combination or<br />
alone, or chemotherapy and/or immunotherapy<br />
with palliative intent.<br />
Professor Vin Paleri, Project Lead<br />
RECUT study<br />
Get in touch<br />
oraclecancertrust.org<br />
+44 (0) 203 475 3471<br />
info@oraclecancertrust.org<br />
Support Oracle now, donate<br />
today!<br />
Scan here to donate:
Change language